Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Asahi Kasei ( (JP:3407) ).
Asahi Kasei reported its consolidated financial results for the first and second quarters of fiscal 2025, showing a slight decline in net sales by 0.3% compared to the previous year. Despite this, the company experienced a significant increase in net income attributable to owners, rising by 10.0%. The company also revised its fiscal 2025 forecast, anticipating a modest growth in net sales and income. The elimination of six companies, including Asahi Kasei Medical Co., Ltd., from its consolidation scope, indicates a strategic shift in its business operations. The company maintained its cash dividend forecast, reflecting stability in shareholder returns.
The most recent analyst rating on (JP:3407) stock is a Buy with a Yen1600.00 price target. To see the full list of analyst forecasts on Asahi Kasei stock, see the JP:3407 Stock Forecast page.
More about Asahi Kasei
Asahi Kasei Corporation is a diversified Japanese company operating in various industries, including chemicals, electronics, and healthcare. The company is known for its innovative products and solutions, focusing on sustainability and technological advancements to meet the evolving needs of global markets.
Average Trading Volume: 4,105,651
Technical Sentiment Signal: Buy
Current Market Cap: Yen1607.3B
Learn more about 3407 stock on TipRanks’ Stock Analysis page.